Thomas Schwarzlmüller

757 total citations · 1 hit paper
15 papers, 547 citations indexed

About

Thomas Schwarzlmüller is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Thomas Schwarzlmüller has authored 15 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Thomas Schwarzlmüller's work include Medical Imaging Techniques and Applications (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Advanced MRI Techniques and Applications (3 papers). Thomas Schwarzlmüller is often cited by papers focused on Medical Imaging Techniques and Applications (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Advanced MRI Techniques and Applications (3 papers). Thomas Schwarzlmüller collaborates with scholars based in Norway, Denmark and France. Thomas Schwarzlmüller's co-authors include Martin Biermann, Charalampos Tzoulis, Kristoffer Haugarvoll, Alexander R. Craven, Renate Grüner, Njål Brekke, Laurence A. Bindoff, Karsten Specht, Christian Dölle and Gia Tuong Tran and has published in prestigious journals such as PLoS ONE, Brain and Cell Metabolism.

In The Last Decade

Thomas Schwarzlmüller

15 papers receiving 542 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease

2022 186 citations Brage Brakedal, Christian Dölle et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Schwarzlmüller Norway	9	168	145	102	99	92	15	547
Virginie Dinet France	13	253 1.5×	66 0.5×	123 1.2×	40 0.4×	108 1.2×	22	585
Chuen‐Lin Huang Taiwan	15	224 1.3×	33 0.2×	67 0.7×	29 0.3×	119 1.3×	23	534
Yaping Yan China	18	257 1.5×	363 2.5×	145 1.4×	46 0.5×	286 3.1×	59	814
Anna Maio Italy	15	198 1.2×	102 0.7×	84 0.8×	81 0.8×	185 2.0×	45	621
Carole Berthet Switzerland	7	192 1.1×	85 0.6×	93 0.9×	19 0.2×	158 1.7×	8	498
Jiunn-Tay Lee Taiwan	9	259 1.5×	157 1.1×	188 1.8×	24 0.2×	73 0.8×	11	596
David T. She Singapore	8	194 1.2×	30 0.2×	43 0.4×	64 0.6×	40 0.4×	10	425
Amber Nolan United States	14	166 1.0×	236 1.6×	251 2.5×	69 0.7×	68 0.7×	31	727
Hans H. Klünemann Germany	13	136 0.8×	130 0.9×	373 3.7×	67 0.7×	41 0.4×	25	821
J. Rao United States	4	52 0.3×	62 0.4×	91 0.9×	52 0.5×	70 0.8×	5	379

Countries citing papers authored by Thomas Schwarzlmüller

Since Specialization

Citations

This map shows the geographic impact of Thomas Schwarzlmüller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schwarzlmüller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schwarzlmüller more than expected).

Fields of papers citing papers by Thomas Schwarzlmüller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schwarzlmüller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schwarzlmüller. The network helps show where Thomas Schwarzlmüller may publish in the future.

Co-authorship network of co-authors of Thomas Schwarzlmüller

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schwarzlmüller. A scholar is included among the top collaborators of Thomas Schwarzlmüller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schwarzlmüller. Thomas Schwarzlmüller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Brakedal, Brage, Christian Dölle, Frank Riemer, et al.. (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease. Cell Metabolism. 34(3). 396–407.e6. 186 indexed citations breakdown →

Schwarzlmüller, Thomas, et al.. (2019). Evaluation of a new e-learning framework for teaching nuclear medicine and radiology to undergraduate medical students. Acta Radiologica Open. 8(7). 1114390631–1114390631. 7 indexed citations

Berntsen, Erik Magnus, Joel Aanerud, Thomas Schwarzlmüller, et al.. (2019). Quantitative and clinical impact of MRI-based attenuation correction methods in [18F]FDG evaluation of dementia. EJNMMI Research. 9(1). 83–83. 8 indexed citations

Flønes, Irene H., Paweł Sztromwasser, Kristoffer Haugarvoll, et al.. (2016). Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy. PLoS ONE. 11(2). e0149055–e0149055. 18 indexed citations

Tzoulis, Charalampos, Thomas Schwarzlmüller, Martin Biermann, Kristoffer Haugarvoll, & Laurence A. Bindoff. (2016). Mitochondrial DNA homeostasis is essential for nigrostriatal integrity. Mitochondrion. 28. 33–37. 30 indexed citations

Eichele, Tom, et al.. (2016). Combined variants in reading epilepsy; coexisting anterior and posterior variants camouflaged as heat cramps where the patient finds his own diagnosis searching the internet. Epilepsy & Behavior Case Reports. 5. 75–77. 1 indexed citations

Tzoulis, Charalampos, Thomas Schwarzlmüller, Ivar Gjerde, et al.. (2015). Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report. BMC Research Notes. 8(1). 171–171. 24 indexed citations

Passow, Susanne, Karsten Specht, Tom Christian Holm Adamsen, et al.. (2015). A close link between metabolic activity and functional connectivity in the resting human brain. EJNMMI Physics. 2(S1). A78–A78. 3 indexed citations

Passow, Susanne, Karsten Specht, Tom Christian Holm Adamsen, et al.. (2015). Default‐mode network functional connectivity is closely related to metabolic activity. Human Brain Mapping. 36(6). 2027–2038. 113 indexed citations

10.

Schwarzlmüller, Thomas, Katrin Brauckhoff, Kristian Løvås, Martin Biermann, & Michael Brauckhoff. (2014). High cardiac background activity limits 99mTc-MIBI radioguided surgery in aortopulmonary window parathyroid adenomas. BMC Surgery. 14(1). 22–22. 3 indexed citations

11.

Tzoulis, Charalampos, Christian A. Vedeler, Mette Haugen, et al.. (2013). Progressive striatal necrosis associated with anti-NMDA receptor antibodies. BMC Neurology. 13(1). 55–55. 20 indexed citations

12.

Tzoulis, Charalampos, Gia Tuong Tran, Thomas Schwarzlmüller, et al.. (2013). Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain. 136(8). 2393–2404. 75 indexed citations

13.

Biermann, Martin, et al.. (2013). Is there a role for PET-CT and SPECT-CT in pediatric oncology?. Acta Radiologica. 54(9). 1037–1045. 25 indexed citations

14.

Bach‐Gansmo, Tore, et al.. (2010). SPECT/CT hybrid imaging; with which CT?. Contrast Media & Molecular Imaging. 5(4). 208–212. 6 indexed citations

15.

Kummer, Wolfgang, Sönke Behrends, Thomas Schwarzlmüller, Axel Fischer, & Doris Koesling. (1996). Subunits of soluble guanylyl cyclase in rat and guinea-pig sensory ganglia. Brain Research. 721(1-2). 191–195. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact